CC
Casdin Capital Portfolio holdings
AUM $1.1B
1-Year Return
24.98%
This Quarter Return
-15.27%
1 Year Return
+24.98%
3 Year Return
+152.8%
5 Year Return
+110.01%
10 Year Return
–
AUM
$3.55B
AUM Growth
-$460M
(-11%)
Cap. Flow
+$243M
Cap. Flow
% of AUM
6.86%
Top 10 Holdings %
Top 10 Hldgs %
53.02%
Holding
59
New
5
Increased
5
Reduced
13
Closed
5
Top Buys
| 1 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$270M |
| 2 |
Guardant Health
GH
|
+$79M |
| 3 |
Sarepta Therapeutics
SRPT
|
+$22.5M |
| 4 |
SNCE
Science 37 Holdings, Inc. Common Stock
SNCE
|
+$22.4M |
| 5 |
Seer Inc
SEER
|
+$14.8M |
Top Sells
| 1 |
Twist Bioscience
TWST
|
+$25.5M |
| 2 |
Exact Sciences
EXAS
|
+$24.9M |
| 3 |
Ginkgo Bioworks
DNA
|
+$23.9M |
| 4 |
Syndax Pharmaceuticals
SNDX
|
+$22.9M |
| 5 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
+$17.6M |
Sector Composition
| 1 | Healthcare | 94.75% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Stoke Therapeutics
STOK
$1.28B
| $2.88M | 0.08% |
120,000
| – | – |
|
|
LIAN
52
DELISTED
LianBio American Depositary Shares
LIAN
| $1.27M | 0.04% |
+206,415
| New | +$1.27M |
|
53
Sana Biotechnology
SANA
$831M
| $929K | 0.03% |
60,000
| – | – |
|
|
54
Syndax Pharmaceuticals
SNDX
$1.36B
| – | – |
-1,200,000
| Closed | -$22.9M |
|
55
Alpha Teknova
TKNO
$242M
| – | – |
-300,000
| Closed | -$7.47M |
|
56
Vertex Pharmaceuticals
VRTX
$101B
| – | – |
0
| – | – |
|
|
ORTX
57
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
| – | – |
-257,500
| Closed | -$5.92M |
|
58
Foghorn Therapeutics
FHTX
$282M
| – | – |
-215,000
| Closed | -$3M |
|
59
Nautilus Biotechnolgy
NAUT
$97.8M
| – | – |
-225,000
| Closed | -$1.38M |
|